3 | SEC Filings Hub

Filing metadata

Accession number: 0001415889-22-003341
Form type: Form 3
Filer: NRX Pharmaceuticals, Inc.
CIK: CIK 1719406
Filed: Mar 24, 2022
Reporting period: Mar 15, 2022
Description: Initial ownership

Documents

0001415889-22-003341-index.htm

Complete submission

0001415889-22-003341.txt

directory listing

Filed by

NRX Pharmaceuticals, Inc.